Inspire Medical Systems, Inc.
INSP
$91.75
-$1.17-1.26%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 10.82% | 22.75% | 24.52% | 32.54% | 29.65% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 10.82% | 22.75% | 24.52% | 32.54% | 29.65% |
| Cost of Revenue | 16.18% | 24.04% | 28.28% | 32.88% | 23.05% |
| Gross Profit | 9.86% | 22.52% | 23.88% | 32.48% | 30.91% |
| SG&A Expenses | 20.77% | 14.86% | 14.02% | 15.14% | 17.28% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 15.52% | 13.15% | 13.44% | 13.25% | 13.77% |
| Operating Income | -165.03% | 90.24% | 242.95% | 206.29% | 130.72% |
| Income Before Tax | -121.50% | 144.46% | 140.39% | 347.88% | 192.40% |
| Income Tax Expenses | 19.66% | 79.54% | 196.02% | 437.94% | 392.06% |
| Earnings from Continuing Operations | -136.68% | 129.91% | 138.60% | 316.59% | 181.94% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -136.68% | 129.91% | 138.60% | 316.59% | 181.94% |
| EBIT | -165.03% | 90.24% | 242.95% | 206.29% | 130.72% |
| EBITDA | -98.49% | 110.84% | 239.75% | 227.37% | 140.66% |
| EPS Basic | -136.95% | 129.81% | 136.13% | 312.90% | 180.56% |
| Normalized Basic EPS | -84.08% | 144.33% | 137.90% | 343.67% | 190.84% |
| EPS Diluted | -138.03% | 129.41% | 132.40% | 306.33% | 178.05% |
| Normalized Diluted EPS | -83.71% | 143.47% | 136.38% | 337.65% | 188.80% |
| Average Basic Shares Outstanding | -0.75% | 0.29% | 1.05% | 1.75% | 1.71% |
| Average Diluted Shares Outstanding | -2.96% | 2.35% | 1.70% | 4.32% | 4.03% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |